Print

Biosense Webster, Inc. (JNJ) Announces Launch of the CARTO┬« 3 MEM Base Version  
8/13/2012 9:38:34 AM

DIAMOND BAR, Calif.--(BUSINESS WIRE)--Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the launch of the new CARTO® 3 MEM (Multi-Electrode Mapping) Version in the United States.
//-->